Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses Rituximab Biosimilars In Follicular Lymphoma. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
